February 14, 2017 / 7:11 AM / 9 months ago

BRIEF-Moberg Pharma Q4 EBITDA rises

Feb 14 (Reuters) - Moberg Pharma Ab (Publ)

* Q4 net sales sek 89.4 million (53.7)

* Q4 ebitda sek 12.0 million (4.0)

* Q4 net profit after tax SEK -2.5 million (0.4)

* Says additional tax bookings related to transactions resulted in a negative net profit after tax in Q4. Says company has deferred tax assets and corporate tax paid was therefore is insignificant

* Proposes that no dividend be paid for the 2016 financial year Further company coverage: (Reporting by Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below